Medtronic announces 510(k) clearance for pillcam™ small bowel 3 @home endoscopy procedure

Dublin, nov. 15, 2021 /prnewswire/ -- medtronic plc (nyse:mdt), a global leader in healthcare technology, today announced that the u.s. food and drug administration (fda) has granted 510(k) clearance for its pillcam™ small bowel 3 system for remote endoscopy procedures. the pillcam™ sb3 @home program combines medtronic's pillcam technology with amazon logistics, a combination intended to ensure both timely and accurate results for patients from the comfort of their homes.
MDT Ratings Summary
MDT Quant Ranking